Reduction of Allogeneic Transplant Morbidity by Combining Peripheral Blood and Bone Marrow Progenitor Cells
- 1 January 1993
- journal article
- case report
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 10 (4-5) , 405-406
- https://doi.org/10.3109/10428199309148568
Abstract
One case has been reported of a patient undergoing allogeneic transplantation with peripheral blood progenitor cells (PBPCs) rather than bone marrow.1 We now report the first case of a patient who underwent an allogeneic transplant with bone marrow combined with PBPCs.Keywords
This publication has 3 references indexed in Scilit:
- Phase I/II trial of recombinant human granulocyte-macrophage colony- stimulating factor following allogeneic bone marrow transplantationBlood, 1991
- GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR TO HARVEST CIRCULATING HAEMOPOIETIC STEM CELLS FOR AUTOTRANSPLANTATIONThe Lancet, 1989
- Granulocyte Transfusions for the Prevention of Infection in Patients Receiving Bone-Marrow TransplantsNew England Journal of Medicine, 1978